Study to Evaluate Safety and Efficacy of Rifamycin SV MMX in Treating Traveler's Diarrhea in Children Age 12 to 17 Years
Clinical trial NCT04027894 · UNKNOWN
Trial details
- NCT number
- NCT04027894
- Sponsor
- RedHill Biopharma Limited
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-01
- Primary completion
- 2025-01-01
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.